Abstract:Objective: To elucidate potential molecular mechanisms differentiating osteoarthritis (OA) and rheumatoid arthritis (RA) through a bioinformatics analysis of differentially expressed genes (DEGs) in patient synovial cells, aiming to provide new insights for clinical treatment strategies. Materials and methods: Gene expression datasets GSE1919, GSE82107, and GSE77298 were downloaded from the Gene Expression Omnibus (GEO) database to serve as the training groups, with GSE55235 being used as the validation dataset. The OA and RA data from the GSE1919 dataset were merged with the standardized data from GSE82107 and GSE77298, followed by batch effect removal to obtain the merged datasets of differential expressed genes (DEGs) for OA and RA. Intersection analysis was conducted on the DEGs between the two conditions to identify commonly upregulated and downregulated DEGs. Enrichment analysis was then performed on these common co-expressed DEGs, and a protein-protein interaction (PPI) network was constructed to identify hub genes. These hub genes were further analyzed using the GENEMANIA online platform and subjected to enrichment analysis. Subsequent validation analysis was conducted using the GSE55235 dataset. Results: The analysis of differentially expressed genes in the synovial cells from patients with Osteoarthritis (OA) and Rheumatoid Arthritis (RA), compared to a control group (individuals without OA or RA), revealed significant changes in gene expression patterns. Specifically, the genes APOD, FASN, and SCD were observed to have lower expression levels in the synovial cells of both OA and RA patients, indicating downregulation within the pathological context of these diseases. In contrast, the SDC1 gene was found to be upregulated, displaying higher expression levels in the synovial cells of OA and RA patients compared to normal controls.Additionally, a noteworthy observation was the downregulation of the transcription factor PPARG in the synovial cells of patients with OA and RA. The decrease in expression levels of PPARG further validates the alteration in lipid metabolism and inflammatory processes associated with the pathogenesis of OA and RA. These findings underscore the significance of these genes and the transcription factor not only as biomarkers for differential diagnosis between OA and RA but also as potential targets for therapeutic interventions aimed at modulating their expression to counteract disease progression. Conclusion: The outcomes of this investigation reveal the existence of potentially shared molecular mechanisms within Osteoarthritis (OA) and Rheumatoid Arthritis (RA). The identification of APOD, FASN, SDC1, TNFSF11 as key target genes, along with their downstream transcription factor PPARG, highlights common potential factors implicated in both diseases. A deeper examination and exploration of these findings could pave the way for new candidate targets and directions in therapeutic research aimed at treating both OA and RA. This study underscores the significance of leveraging bioinformatics approaches to unravel complex disease mechanisms, offering a promising avenue for the development of more effective and targeted treatments.

Differences in gene expressions between synovioblast and skin fibroblast in patients with osteoarthritis

Extensive cytokine analysis in synovial fluid of osteoarthritis patients

Analysis of common differential gene expression in synovial cells of osteoarthritis and rheumatoid arthritis

The secretion of proinflammatory cytokines and chemokines in stimulated fibroblast-like synoviocytes of osteoarthritis

Parallel Comparison of Fibroblast-Like Synoviocytes from the Surgically Removed Hyperplastic Synovial Tissues of Rheumatoid Arthritis and Osteoarthritis Patients

Genes Relevant with Osteoarthritis by Comparison Gene Expression Profiles of Synovial Membrane of Osteoarthritis Patients at Different Stages.

A comprehensive analysis of biomarkers associated with synovitis and chondrocyte apoptosis in osteoarthritis

Proteomic analysis of synovial tissue in rheumatoid arthritis, OLFM4 promotes fibroblast like synoviocytes proliferation in RA

Identification of key biomarkers and immune infiltration in the synovial tissue of osteoarthritis by bioinformatics analysis

Bioinformatics analysis of differences in synovial cell composition and metabolism of hip joint

Expression of oncostatin M in knee osteoarthritis

Gene expression profile in the synovium of patients with knee osteoarthritis in Yanbian area

POTENTIAL KEY BIOMARKERS OF OSTEOARTHRITIS BY INTEGRATIVE GENOME-WIDE GENE EXPRESSION PROFILING ANALYSIS

Synovium and cartilage gene expression in chronic arthritis versus normal rats

Identification and validation of hub genes of synovial tissue for patients with osteoarthritis and rheumatoid arthritis

EXPRESSION OF GLYCAN-RELATED GENES IN PERIPHERAL LEUCOCYTES OF OSTEOARTHRITIS PATIENTS

Proteomic analysis of synovial fluid: insight into the pathogenesis of knee osteoarthritis

Combined Bioinformatics Analysis Reveals Gene Expression and DNA Methylation Patterns in Osteoarthritis.

Upregulation of fibroblast growth factor 1 in the synovial membranes of patients with late stage osteoarthritis

Differentially Expressed Serum Proteins in Knee Osteoarthritis Patients Compared with Normal Subjects

Comparison of the Status of Tyrosine Phosphorylation in Fibroblast Like Synoviocytes Between Rheumatoid Arthritis and Osteoarthritis